[1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium

C147H226N28O15S5+2 — CID 159360099

IUPAC[1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium
SMILESCCCCc1nc2c(N)nc3ccccc3c2n1CCCCCC(=O)CCC(=O)NCCCCC(NC)C(C)=O.CCCCc1nc2c(N)nc3ccccc3c2n1CCCCNC(=O)CCCCCCC(=O)CCSSCCCC(=[NH2+])CCCCCC(NC)C(C)=O.CCCCc1nc2c(N)nc3ccccc3c2n1CCCCNC(=O)CCN1C(=O)CC(SCC(=O)NCCCCC(NC)C(C)=O)C1=O.CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)NC(=O)CCCCCCC(=O)CCSSCCCC(=[NH2+])CCCCCC(NC)C(C)=O
InChIInChI=1S/C41H65N7O3S2.C40H63N7O4S2.C35H50N8O5S.C31H46N6O3/c1-4-5-24-37-47-39-40(34-21-13-14-23-36(34)46-41(39)43)48(37)28-16-15-27-45-38(51)25-12-7-6-10-20-33(50)26-30-53-52-29-17-19-32(42)18-9-8-11-22-35(44-3)31(2)49;1-6-51-27-35-45-37-38(32-20-14-15-22-34(32)44-39(37)42)47(35)28-40(3,4)46-36(50)23-13-8-7-11-19-31(49)24-26-53-52-25-16-18-30(41)17-10-9-12-21-33(43-5)29(2)48;1-4-5-15-28-41-32-33(24-12-6-7-14-26(24)40-34(32)36)42(28)19-11-10-18-38-29(45)16-20-43-31(47)21-27(35(43)48)49-22-30(46)39-17-9-8-13-25(37-3)23(2)44;1-4-5-17-27-36-29-30(24-14-8-9-16-26(24)35-31(29)32)37(27)21-12-6-7-13-23(39)18-19-28(40)34-20-11-10-15-25(33-3)22(2)38/h13-14,21,23,35,42,44H,4-12,15-20,22,24-30H2,1-3H3,(H2,43,46)(H,45,51);14-15,20,22,33,41,43H,6-13,16-19,21,23-28H2,1-5H3,(H2,42,44)(H,46,50);6-7,12,14,25,27,37H,4-5,8-11,13,15-22H2,1-3H3,(H2,36,40)(H,38,45)(H,39,46);8-9,14,16,25,33H,4-7,10-13,15,17-21H2,1-3H3,(H2,32,35)(H,34,40)/p+2
InChIKeyLIKULXGDYOUWRU-UHFFFAOYSA-P
MW2785.94 g/mol
LogP21.58
Rot. Bonds100

About [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium

[1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium (PubChem CID 159360099) has the molecular formula C147H226N28O15S5+2 and a molecular weight of 2785.94 g/mol. Its IUPAC name is [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium.

Molecular Properties

Compound Name[1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium
PubChem CID159360099
Molecular FormulaC147H226N28O15S5+2
Molecular Weight2785.94 g/mol
Exact Mass2783.64
IUPAC Name[1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium
SMILESCCCCc1nc2c(N)nc3ccccc3c2n1CCCCCC(=O)CCC(=O)NCCCCC(NC)C(C)=O.CCCCc1nc2c(N)nc3ccccc3c2n1CCCCNC(=O)CCCCCCC(=O)CCSSCCCC(=[NH2+])CCCCCC(NC)C(C)=O.CCCCc1nc2c(N)nc3ccccc3c2n1CCCCNC(=O)CCN1C(=O)CC(SCC(=O)NCCCCC(NC)C(C)=O)C1=O.CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)NC(=O)CCCCCCC(=O)CCSSCCCC(=[NH2+])CCCCCC(NC)C(C)=O
InChIInChI=1S/C41H65N7O3S2.C40H63N7O4S2.C35H50N8O5S.C31H46N6O3/c1-4-5-24-37-47-39-40(34-21-13-14-23-36(34)46-41(39)43)48(37)28-16-15-27-45-38(51)25-12-7-6-10-20-33(50)26-30-53-52-29-17-19-32(42)18-9-8-11-22-35(44-3)31(2)49;1-6-51-27-35-45-37-38(32-20-14-15-22-34(32)44-39(37)42)47(35)28-40(3,4)46-36(50)23-13-8-7-11-19-31(49)24-26-53-52-25-16-18-30(41)17-10-9-12-21-33(43-5)29(2)48;1-4-5-15-28-41-32-33(24-12-6-7-14-26(24)40-34(32)36)42(28)19-11-10-18-38-29(45)16-20-43-31(47)21-27(35(43)48)49-22-30(46)39-17-9-8-13-25(37-3)23(2)44;1-4-5-17-27-36-29-30(24-14-8-9-16-26(24)35-31(29)32)37(27)21-12-6-7-13-23(39)18-19-28(40)34-20-11-10-15-25(33-3)22(2)38/h13-14,21,23,35,42,44H,4-12,15-20,22,24-30H2,1-3H3,(H2,43,46)(H,45,51);14-15,20,22,33,41,43H,6-13,16-19,21,23-28H2,1-5H3,(H2,42,44)(H,46,50);6-7,12,14,25,27,37H,4-5,8-11,13,15-22H2,1-3H3,(H2,36,40)(H,38,45)(H,39,46);8-9,14,16,25,33H,4-7,10-13,15,17-21H2,1-3H3,(H2,32,35)(H,34,40)/p+2
InChIKeyLIKULXGDYOUWRU-UHFFFAOYSA-P
XLogP21.58
TPSA637.82 Ų
H-Bond Donors15
H-Bond Acceptors40
Rotatable Bonds100
Heavy Atoms195
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002785.94
LogP ≤ 521.58
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1040

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'disulphide', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium?
The IUPAC name of [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium (CID 159360099) is [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium.
What is the SMILES notation for [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium?
The canonical SMILES for [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium is CCCCc1nc2c(N)nc3ccccc3c2n1CCCCCC(=O)CCC(=O)NCCCCC(NC)C(C)=O.CCCCc1nc2c(N)nc3ccccc3c2n1CCCCNC(=O)CCCCCCC(=O)CCSSCCCC(=[NH2+])CCCCCC(NC)C(C)=O.CCCCc1nc2c(N)nc3ccccc3c2n1CCCCNC(=O)CCN1C(=O)CC(SCC(=O)NCCCCC(NC)C(C)=O)C1=O.CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)NC(=O)CCCCCCC(=O)CCSSCCCC(=[NH2+])CCCCCC(NC)C(C)=O.
What is the InChIKey of [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium?
The InChIKey is LIKULXGDYOUWRU-UHFFFAOYSA-P. The full InChI is InChI=1S/C41H65N7O3S2.C40H63N7O4S2.C35H50N8O5S.C31H46N6O3/c1-4-5-24-37-47-39-40(34-21-13-14-23-36(34)46-41(39)43)48(37)28-16-15-27-45-38(51)25-12-7-6-10-20-33(50)26-30-53-52-29-17-19-32(42)18-9-8-11-22-35(44-3)31(2)49;1-6-51-27-35-45-37-38(32-20-14-15-22-34(32)44-39(37)42)47(35)28-40(3,4)46-36(50)23-13-8-7-11-19-31(49)24-26-53-52-25-16-18-30(41)17-10-9-12-21-33(43-5)29(2)48;1-4-5-15-28-41-32-33(24-12-6-7-14-26(24)40-34(32)36)42(28)19-11-10-18-38-29(45)16-20-43-31(47)21-27(35(43)48)49-22-30(46)39-17-9-8-13-25(37-3)23(2)44;1-4-5-17-27-36-29-30(24-14-8-9-16-26(24)35-31(29)32)37(27)21-12-6-7-13-23(39)18-19-28(40)34-20-11-10-15-25(33-3)22(2)38/h13-14,21,23,35,42,44H,4-12,15-20,22,24-30H2,1-3H3,(H2,43,46)(H,45,51);14-15,20,22,33,41,43H,6-13,16-19,21,23-28H2,1-5H3,(H2,42,44)(H,46,50);6-7,12,14,25,27,37H,4-5,8-11,13,15-22H2,1-3H3,(H2,36,40)(H,38,45)(H,39,46);8-9,14,16,25,33H,4-7,10-13,15,17-21H2,1-3H3,(H2,32,35)(H,34,40)/p+2.
What are the key properties of [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium?
[1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium has a molecular weight of 2785.94 g/mol, XLogP of 21.58, 100 rotatable bonds, 15 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[[10-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butylamino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium;N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)butyl]-3-[3-[2-[[5-(methylamino)-6-oxoheptyl]amino]-2-oxoethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]propanamide;9-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)-N-[5-(methylamino)-6-oxoheptyl]-4-oxononanamide;[1-[[10-[[1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-yl]amino]-3,10-dioxodecyl]disulfanyl]-10-(methylamino)-11-oxododecan-4-ylidene]azanium is sourced from PubChem (CID 159360099), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).